Introducing OncoFlow-Profiler: our state-of-the-art high-throughput screening solution crafted to fast-track the detection of your target antigen expression in a well-established panel of 160 cancer cell lines. Within just 2 weeks, you can obtain high-quality flow cytometry data, facilitating early informed decisions in the ADC drug discovery process.

Contact Us

 

Why choose OncoFlow-Profiler?

1

High-throughput screening platform, with access to 160 well-established cancer cell lines

2

Quick turnaround; get results within 2 weeks

3

Detects carbohydrate-based antigens, remarkably adept at detecting subtle post-translational modifications

4

Accurate and reliable results reflecting years of protocol optimization

Discover our be-spoke experimental workflow

bg-2
View More

We assure top-quality data, a testament to years of protocol validation and optimization

Each stage of our experimental protocol is rigorously validated. Through careful internal validation of our protocols, we aim to provide data of the utmost quality. In the following graphs, we present a typical validation study focusing on the expression of HER2 as a target antigen. This study examines the impact of fixation and assesses the stability of the OncoFlow-Profiler vials under various storage conditions. Furthermore, we highlight a strong correlation between OncoFlow-Profiler data and gene amplification data, underscoring its reliability.

Fixation does not impact the 
stability of the the HER2 receptor
 
grap-1
OncoFlow-Profiler vials remain stable 
over time in different storage conditions
 
grap-2
Strong correlation of OncoFlow-Profiler 
data with gene amplification data
 
grap-3
x

Take the guesswork out of target antigen expression

Reach out to explore the power of OncoFlow-Profiler now.